Increlex

Mecasermin

Clinical data
AHFS/Drugs.com	Monograph
Pregnancy category	US: C (Risk not ruled out)
Routes of administration	Subcutaneous
ATC code	H01AC03 (WHO)
Legal status
Legal status	US: ℞-only
Identifiers
CAS Number	68562-41-4 N
DrugBank	DB01277 N
ChemSpider	none
UNII	7GR9I2683O
KEGG	D04870 N
ChEMBL	CHEMBL1201716 N
Chemical and physical data
Formula	C331H512N94O101S7
Molar mass	7648.67 g/mol
NY (what is this?)

Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in children with severe primary IGF-I deficiency.

This drug is not to be confused with mecasermin rinfabate (trade name Iplex), which is a combination of recombinant human IGF-1 (rhIGF-1) and insulin-like growth factor binding protein-3 (IGFBP-3). IGFBP-3 serves to prolong the action of IGF-1 in the human body.

...
Wikipedia